Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha
- PMID: 19619477
- PMCID: PMC2711320
- DOI: 10.1016/j.bpj.2009.05.009
Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha
Abstract
In circulation, plasma glycoprotein von Willebrand Factor plays an important role in hemostasis and in pathological thrombosis under hydrodynamic forces. Mutations in the A1 domain of von Willebrand factor cause the hereditary types 2B and 2M von Willebrand disease that either enhance (2B) or inhibit (2M) the interaction of von Willebrand factor with the platelet receptor glycoprotein Ibalpha. To understand how type 2B and 2M mutations cause clinically opposite phenotypes, we use a combination of protein unfolding thermodynamics and atomic force microscopy to assess the effects of two type 2B mutations (R1306Q and I1309V) and a type 2M mutation (G1324S) on the conformational stability of the A1 domain and the single bond dissociation kinetics of the A1-GPIbalpha interaction. At physiological temperature, the type 2B mutations destabilize the structure of the A1 domain and shift the A1-GPIbalpha catch to slip bonding to lower forces. Conversely, the type 2M mutation stabilizes the structure of the A1 domain and shifts the A1-GPIbalpha catch to slip bonding to higher forces. As a function of increasing A1 domain stability, the bond lifetime at low force decreases and the critical force required for maximal bond lifetime increases. Our results are able to distinguish the clinical phenotypes of these naturally occurring mutations from a thermodynamic and biophysical perspective that provides a quantitative description of the allosteric coupling of A1 conformational stability with the force dependent catch to slip bonding between A1 and GPIbalpha.
Figures







Similar articles
-
The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.J Biol Chem. 2013 Nov 8;288(45):32289-32301. doi: 10.1074/jbc.M113.504001. Epub 2013 Sep 23. J Biol Chem. 2013. PMID: 24062306 Free PMC article. Clinical Trial.
-
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.J Clin Invest. 2008 Sep;118(9):3195-207. doi: 10.1172/JCI35754. J Clin Invest. 2008. PMID: 18725999 Free PMC article.
-
The mechanism of VWF-mediated platelet GPIbalpha binding.Biophys J. 2010 Aug 9;99(4):1192-201. doi: 10.1016/j.bpj.2010.06.002. Biophys J. 2010. PMID: 20713003 Free PMC article.
-
Platelet adhesion: a game of catch and release.J Clin Invest. 2008 Sep;118(9):3009-11. doi: 10.1172/JCI36883. J Clin Invest. 2008. PMID: 18725992 Free PMC article. Review.
-
A biophysical view on von Willebrand factor activation.J Cell Physiol. 2018 Feb;233(2):799-810. doi: 10.1002/jcp.25887. Epub 2017 May 16. J Cell Physiol. 2018. PMID: 28256724 Review.
Cited by
-
Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.J Mol Biol. 2020 Jan 17;432(2):305-323. doi: 10.1016/j.jmb.2019.09.022. Epub 2019 Oct 17. J Mol Biol. 2020. PMID: 31628947 Free PMC article.
-
Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain.Blood. 2023 Mar 9;141(10):1221-1232. doi: 10.1182/blood.2022017239. Blood. 2023. PMID: 36580664 Free PMC article.
-
Structure-resolved dynamics of type 2M von Willebrand disease.J Thromb Haemost. 2025 Apr;23(4):1215-1228. doi: 10.1016/j.jtha.2024.12.026. Epub 2025 Jan 3. J Thromb Haemost. 2025. PMID: 39756657
-
Urea-temperature phase diagrams capture the thermodynamics of denatured state expansion that accompany protein unfolding.Protein Sci. 2013 Sep;22(9):1147-60. doi: 10.1002/pro.2301. Epub 2013 Jul 25. Protein Sci. 2013. PMID: 23813497 Free PMC article.
-
Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping.J Mol Biol. 2017 Jul 7;429(14):2161-2177. doi: 10.1016/j.jmb.2017.05.013. Epub 2017 May 19. J Mol Biol. 2017. PMID: 28533135 Free PMC article.
References
-
- von Willebrand E. Hereditary pseudohemophilia. Finska Läkarssällskapetes Handl. 1926;68:87–112.
-
- Federici A.B., Mannucci P.M. Management of inherited von Willebrand disease in 2007. Ann. Med. 2007;39:346–358. - PubMed
-
- Keeney S., Cumming A.M. The molecular biology of von Willebrand disease. Clin. Lab. Haematol. 2001;23:209–230. - PubMed
-
- Sadler J.E. Biochemistry and genetics of von Willebrand factor. Annu. Rev. Biochem. 1998;67:395–424. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials